Listen Now

Topics Covered

  • Overview of Chronic Myelogenous Leukemia (CML), in the Context of COVID-19
  • Current Standard of Care, New Treatment Approaches & Clinical Trials
  • Managing Post Treatment Side Effects/Late Effects
  • Adherence: Taking Your Pills on Schedule
  • The Importance of Treatment Summaries
  • Benefits of Follow-Up Care
  • The Importance of Communicating with Your Health Care Team
  • Quality-of-Life Concerns
  • Questions for Our Panel of Experts

Our Panel of Experts

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

Neil P. Shah, MD, PhD

Edward S. Ageno Distinguished Professor in Hematology/Oncology, Director, UCSF Molecular Medicine Residency Program, Leader, Hematopoietic Malignancies Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco

Elias Jabbour, MD

Professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop (pdf)

Workshop Date

This workshop was originally recorded on June 09, 2020.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.